Thrombin Generation in Crohn's Disease
Correlation Between Thrombin Generation and Endoscopic Activity in Crohn's Disease
1 other identifier
observational
150
1 country
3
Brief Summary
One hundred and fifty patients with Crohn's disease involving the terminal ileum or the colon, in clinical remission, with or without endoscopic activity will be included. Thrombin generation will be measured and correlated with the simplified endoscopic activity score. The patients will be evaluated for development of deep vein thrombosis after one-year of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2015
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 12, 2015
CompletedFirst Posted
Study publicly available on registry
May 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMay 12, 2016
May 1, 2015
1.9 years
May 12, 2015
May 11, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between thrombin generation and endoscopic activity
At the moment of the inclusion
Secondary Outcomes (1)
Association of a high thrombin generation and development of deep vein thrombosis
After 1 year of follow up
Study Arms (2)
Clinical remission without inflammation
Patients with Crohn's disease in clinical remission and no inflammation in the colonoscopy
Clinical remission with inflammation
Patients with Crohn's disease in clinical remission and active inflammation in the colonoscopy
Eligibility Criteria
Patients with established Crohn's disease with stable treatment and clinical remission
You may qualify if:
- Established Crohn's disease diagnosis for at least 6 months
- Disease involvement of the terminal ileum and/or colon
- Clinical remission
- Stable treatment for at least 3 months
You may not qualify if:
- Colectomy
- Neoplasia
- Surgery in the last 6 months
- Anticoagulant treatment
- Major liver disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Universidade do Vale do Itajaí-UNIVALI / Santa Catarina
Itajaí, Santa Catarina, Brazil
Faculdade de Medicina de Botucatu -UNESP
Botucatú, São Paulo, 18607-621, Brazil
Clinical Hospital of São Paulo University
São Paulo, São Paulo, 05403-010, Brazil
Biospecimen
5ml of plasm
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andre ZA Leite, MD
Clinical Hospital of São Paulo University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2015
First Posted
May 15, 2015
Study Start
May 1, 2015
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
May 12, 2016
Record last verified: 2015-05